The Mylan plant in Morgantown, West Virginia willl restart production of hydroxychloroquine this week.
The drug was touted by researchers, doctors and President Trump in the treatment of the COVID-19 virus.
Advertisement - story continues below
Generic Drug Company Teva in Israel is also mass-producing the drug to save lives.
Many of the drugs will come from a plant in Morgantown W. Va., in case any are worried about Chinese sourcing.
— Stephen Smoot (@S_A_Smoot) March 22, 2020
TRENDING: Canceled Hollywood Star Bursts Into Tears as Conservative Audience Gives Standing Ovation
The Dominion Post reported:
Mylan’s Morgantown plant is restarting production of an anti-malaria medication that is under study as a potential treatment for the COVID-19 virus.
Advertisement - story continues below
The drug is hydroxychloroquine sulfate; the tablets are approved by the U.S. Food and Drug Administration for the treatment of malaria, lupus erythematosus and rheumatoid arthritis.
President Trump on Thursday touted its cousin, chloroquine, as a potential treatment and mistakenly said it has been FDA approved for COVID-19.
Mylan clarified, “Although the product is not currently approved for use in the treatment of COVID-19, it is listed by the World Health Organization as a drug under investigation for efficacy against the coronavirus.”
The drug had been in short supply earlier in March, according to news reports, but Mylan and another generic drug firm, Israel-based Teva, are both ramping up production.
The Gateway Pundit is moving back to Disqus! All of your account information and comment history has been saved and will be uploaded as quickly as possible to Disqus. If you do not already have a Disqus account, you will need to create one. Please use the same email address that you used for Insticator for your comment history to be carried over. We greatly appreciate your patience and continued support!